Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Trends in overleving bij uitgezaaid melanoom: analyse 2013-2021
apr 2024 | Dermato-oncologie